300 related articles for article (PubMed ID: 28004320)
1. Sensitivity and responsiveness of the EQ-5D-3L in patients with uncontrolled focal seizures: an analysis of Phase III trials of adjunctive brivaracetam.
Mukuria C; Young T; Keetharuth A; Borghs S; Brazier J
Qual Life Res; 2017 Mar; 26(3):749-759. PubMed ID: 28004320
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the responsiveness of EQ-5D-5L and the QOLIE-31P and mapping of QOLIE-31P to EQ-5D-5L in epilepsy.
Wijnen BFM; Mosweu I; Majoie MHJM; Ridsdale L; de Kinderen RJA; Evers SMAA; McCrone P
Eur J Health Econ; 2018 Jul; 19(6):861-870. PubMed ID: 28871490
[TBL] [Abstract][Full Text] [Related]
3. EuroQOL-5D-3L does not adequately map quality-of-life deterioration in severely affected patients with epilepsy.
Willems LM; Knake S; Rosenow F; Reese JP; Conradi N; Strzelczyk A
Epilepsy Behav; 2022 Feb; 127():108554. PubMed ID: 35063789
[TBL] [Abstract][Full Text] [Related]
4. Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D.
Mulhern B; Pink J; Rowen D; Borghs S; Butt T; Hughes D; Marson A; Brazier J
Value Health; 2017 Apr; 20(4):687-693. PubMed ID: 28408012
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in double-blind Phase III studies of brivaracetam as adjunctive therapy of focal seizures: A pooled, post-hoc analysis.
Brandt C; Borghs S; Elmoufti S; Mueller K; Townsend R; de la Loge C
Epilepsy Behav; 2017 Apr; 69():80-85. PubMed ID: 28236727
[TBL] [Abstract][Full Text] [Related]
6. Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosis.
Mukuria C; Rowen D; Acaster S; McGarry LJ; Lou Y; Sosnay PR; Quittner AL
J Patient Rep Outcomes; 2024 Feb; 8(1):24. PubMed ID: 38416239
[TBL] [Abstract][Full Text] [Related]
7. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
8. Assessing the construct validity and responsiveness of Preference-Based Measures (PBMs) in cataract surgery patients.
Breheny K; Hollingworth W; Kandiyali R; Dixon P; Loose A; Craggs P; Grzeda M; Sparrow J
Qual Life Res; 2020 Jul; 29(7):1935-1946. PubMed ID: 32080789
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
Bulamu NB; Vissapragada R; Chen G; Ratcliffe J; Mudge LA; Smithers BM; Isenring EA; Smith L; Jamieson GG; Watson DI;
Health Qual Life Outcomes; 2021 Oct; 19(1):233. PubMed ID: 34600554
[TBL] [Abstract][Full Text] [Related]
10. Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.
Golicki D; Niewada M; Karlińska A; Buczek J; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Jun; 24(6):1555-63. PubMed ID: 25425288
[TBL] [Abstract][Full Text] [Related]
11. The feasibility, repeatability, validity and responsiveness of the EQ-5D-3L in Krio for patients with stroke in Sierra Leone.
Youkee D; Pessima S; Sackley C; Soley-Bori M; Deen GF; Marshall IJ
Health Qual Life Outcomes; 2024 Mar; 22(1):29. PubMed ID: 38549069
[TBL] [Abstract][Full Text] [Related]
12. A vision 'bolt-on' increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery.
Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
Eur J Health Econ; 2020 Jun; 21(4):501-511. PubMed ID: 31902023
[TBL] [Abstract][Full Text] [Related]
13. Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D in assessing mental health.
Crick K; Al Sayah F; Ohinmaa A; Johnson JA
Qual Life Res; 2018 Jun; 27(6):1625-1633. PubMed ID: 29516342
[TBL] [Abstract][Full Text] [Related]
14. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
[TBL] [Abstract][Full Text] [Related]
15. Fighting to Breathe and Fighting for Health-Related Quality of Life: Measuring the Impact of Being Dependent on Technology for Breathing on the Child and Their Caregiver.
Verstraete J; Booth C; Booth J; Peer S; McGuire J; Kritzinger F; Gray T; Zibi N; Shabangu P; Zampoli M
Patient; 2024 Jan; 17(1):65-82. PubMed ID: 37991685
[TBL] [Abstract][Full Text] [Related]
16. Responsiveness of the EQ-5D-3L in elective shoulder surgery: Does it adequately represent patient experience?
Evans J; Dattani R; Ramasamy V; Patel V
J Orthop Surg (Hong Kong); 2018; 26(2):2309499018774922. PubMed ID: 29764325
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.
Xin Y; McIntosh E
Qual Life Res; 2017 Jan; 26(1):1-23. PubMed ID: 27778141
[TBL] [Abstract][Full Text] [Related]
18. Comparison of contemporaneous responses for EQ-5D-3L and Minnesota Living with Heart Failure; a case for disease specific multiattribute utility instrument in cardiovascular conditions.
Kularatna S; Byrnes J; Chan YK; Carrington MJ; Stewart S; Scuffham PA
Int J Cardiol; 2017 Jan; 227():172-176. PubMed ID: 27865116
[TBL] [Abstract][Full Text] [Related]
19. Reliability and validity of QOLIE-10 in measuring health-related quality of life (HRQoL) in Chinese epilepsy patients.
Gao L; Xia L; Pan SQ; Xiong T; Li SC
Epilepsy Res; 2014 Mar; 108(3):565-75. PubMed ID: 24534759
[TBL] [Abstract][Full Text] [Related]
20. Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping.
Gray LA; Wailoo AJ; Hernandez Alava M
Value Health; 2018 Dec; 21(12):1399-1405. PubMed ID: 30502783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
